Intensity-modulated radiation therapy followed by GDP chemotherapy for newly diagnosed stage I/II extranodal natural killer/T cell lymphoma, nasal type

Annals of Hematology ◽

10.1007/s00277-017-3046-2 ◽

2017 ◽

Vol 96 (9) ◽

pp. 1477-1483 ◽

Author(s):

Yu Huang ◽

Jianliang Yang ◽

Peng Liu ◽

Shengyu Zhou ◽

Lin Gui ◽

...

Keyword(s):

Radiation Therapy ◽

T Cell ◽

Natural Killer ◽

Cell Lymphoma ◽

Intensity Modulated Radiation Therapy ◽

Newly Diagnosed ◽

Natural Killer T Cell ◽

Intensity Modulated ◽

Download Full-text

Sintilimab With P-GemOx Regimen for Newly Diagnosed Advanced Extranodal Natural Killer/T-cell Lymphoma, Nasal Type

Case Medical Research ◽

10.31525/ct1-nct04127227 ◽

2019 ◽

Author(s):

Keyword(s):

T Cell ◽

Natural Killer ◽

Cell Lymphoma ◽

T Cell Lymphoma ◽

Newly Diagnosed ◽

Natural Killer T Cell ◽

Killer T Cell ◽

Natural Killer T

Download Full-text

A phase II prospective clinical study of the “sandwich” protocol, VDLP combined with concurrent radiation and cisplatin in newly diagnosed, I/II stage, nasal type, extranodal natural killer/T-cell lymphoma.

Journal of Clinical Oncology ◽

10.1200/jco.2016.34.15_suppl.7553 ◽

2016 ◽

Vol 34 (15_suppl) ◽

pp. 7553-7553

Author(s):

Li Zhang ◽

Ming Jiang ◽

Li Xie ◽

Hong Zhang ◽

Yu Jiang ◽

...

Keyword(s):

Clinical Study ◽

T Cell ◽

Natural Killer ◽

Phase Ii ◽

Cell Lymphoma ◽

Prospective Clinical Study ◽

Newly Diagnosed ◽

Natural Killer T Cell ◽

Download Full-text

A study of gemcitabine,l-asparaginase, ifosfamide, dexamethasone and etoposide chemotherapy for newly diagnosed stage IV, relapsed or refractory extranodal natural killer/T-cell lymphoma, nasal type

Leukemia & Lymphoma ◽

10.3109/10428194.2014.907894 ◽

2014 ◽

Vol 55 (12) ◽

pp. 2955-2957 ◽

Author(s):

Jie Ji ◽

Ting Liu ◽

Bing Xiang ◽

Weiping Liu ◽

Chuan He ◽

...

Keyword(s):

T Cell ◽

Natural Killer ◽

Cell Lymphoma ◽

Stage Iv ◽

T Cell Lymphoma ◽

Newly Diagnosed ◽

Natural Killer T Cell ◽

Killer T Cell ◽

Natural Killer T

Download Full-text

Long-term Efficacy of Sequential DICE Chemotherapy With Regional Field Radiation Therapy for Stages I-II Natural Killer/T-Cell Lymphoma, Nasal Type: Analysis of 118 Cases

International Journal of Radiation Oncology*Biology*Physics ◽

10.1016/j.ijrobp.2015.07.1696 ◽

2015 ◽

Vol 93 (3) ◽

pp. E451

Author(s):

Y. Wang ◽

X. Ma ◽

Y. Guo ◽

X. Li

Keyword(s):

Radiation Therapy ◽

T Cell ◽

Natural Killer ◽

Cell Lymphoma ◽

Type Analysis ◽

Natural Killer T Cell ◽

Field Radiation ◽

Download Full-text

A phase II prospective study of the “Sandwich” protocol, L-asparaginase, cisplatin, dexamethasone and etoposide chemotherapy combined with concurrent radiation and cisplatin, in newly diagnosed, I/II stage, nasal type, extranodal natural killer/T-cell lymphoma

10.18632/oncotarget.16334 ◽

2017 ◽

Vol 8 (30) ◽

pp. 50155-50163 ◽

Author(s):

Ming Jiang ◽

Li Zhang ◽

Li Xie ◽

Hong Zhang ◽

Yu Jiang ◽

...

Keyword(s):

T Cell ◽

Prospective Study ◽

Natural Killer ◽

Phase Ii ◽

Cell Lymphoma ◽

T Cell Lymphoma ◽

Newly Diagnosed ◽

Natural Killer T Cell ◽

Download Full-text

Alarming Rates of Omission or Inadequate Radiation Therapy in Extranodal Natural Killer T-cell Lymphoma Nasal Type in the United States

International Journal of Radiation Oncology*Biology*Physics ◽

10.1016/j.ijrobp.2016.06.415 ◽

2016 ◽

Vol 96 (2) ◽

pp. S164-S165

Author(s):

J. Vargo ◽

G.K. Balasubramani ◽

S. Beriwal

Keyword(s):

United States ◽

Radiation Therapy ◽

T Cell ◽

Natural Killer ◽

Cell Lymphoma ◽

The United States ◽

T Cell Lymphoma ◽

Natural Killer T Cell ◽

Download Full-text

Comparisons of skin toxicity in patients with extranodal nasal-type natural killer/T-cell lymphoma after treatment with intensity-modulated radiotherapy and conventional radiotherapy

Journal of Cancer Research and Therapeutics ◽

10.4103/0973-1482.192791 ◽

2018 ◽

Vol 14 (7) ◽

pp. 975

Author(s):

Daoke Yang ◽

Yue Gu ◽

Hui Yu ◽

Xiaoxiao Zuo ◽

Qinchen Cao ◽

...

Keyword(s):

T Cell ◽

Natural Killer ◽

Cell Lymphoma ◽

Intensity Modulated Radiotherapy ◽

Skin Toxicity ◽

Conventional Radiotherapy ◽

Natural Killer T Cell ◽

Intensity Modulated ◽

Download Full-text

Effectiveness of pegaspargase, gemcitabine, and oxaliplatin (P-GEMOX) chemotherapy combined with radiotherapy in newly diagnosed, stage IE to IIE, nasal-type, extranodal natural killer/T-cell lymphoma

10.1080/10245332.2016.1264163 ◽

2016 ◽

Vol 22 (6) ◽

pp. 320-329 ◽

Author(s):

Wen Wei ◽

Ping Wu ◽

Li Li ◽

Zhi-hui Zhang

Keyword(s):

T Cell ◽

Natural Killer ◽

Cell Lymphoma ◽

T Cell Lymphoma ◽

Newly Diagnosed ◽

Natural Killer T Cell ◽

Killer T Cell ◽

Natural Killer T

Download Full-text

Gemcitabine, dexamethasone, and cisplatin (GDP) chemotherapy with sandwiched radiotherapy in the treatment of newly diagnosed stage IE/IIE extranodal natural killer/T‐cell lymphoma, nasal type

Cancer Medicine ◽

10.1002/cam4.2214 ◽

2019 ◽

Vol 8 (7) ◽

pp. 3349-3358 ◽

Author(s):

Shu Tian ◽

Ruichen Li ◽

Tian Wang ◽

Shengzi Wang ◽

Rong Tao ◽

...

Keyword(s):

T Cell ◽

Natural Killer ◽

Cell Lymphoma ◽

T Cell Lymphoma ◽

Newly Diagnosed ◽

Natural Killer T Cell ◽

Killer T Cell ◽

Natural Killer T

Download Full-text

GDP (Gemcitabine, Dexamethasone, and Cisplatin) Is Highly Effective and Well-Tolerated for Newly Diagnosed Stage IV and Relapsed/Refractory Extranodal Natural Killer/T-Cell Lymphoma, Nasal Type

Medicine ◽

10.1097/md.0000000000002787 ◽

2016 ◽

Vol 95 (6) ◽

pp. e2787 ◽

Author(s):

Jing-jing Wang ◽

Mei Dong ◽

Xiao-hui He ◽

Ye-xiong Li ◽

Wei-hu Wang ◽

...

Keyword(s):

T Cell ◽

Natural Killer ◽

Cell Lymphoma ◽

Stage Iv ◽

T Cell Lymphoma ◽

Newly Diagnosed ◽

Natural Killer T Cell ◽

Killer T Cell ◽

Natural Killer T

Download Full-text